lichen planopilaris
lichen planopilaris
Explore linked clinical trials. Standard reference: MONDO:00188792 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris | Lichenoid Eruptions, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, central centrifugal cicatricial alopecia, lichen planopilaris, lichen planus, skin disorder | Recruiting | Phase 2 | 2026-07-10 | NCT07487948 | |
| A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris | Lichenoid Eruptions, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, lichen planopilaris, lichen planus, skin disorder | Recruiting | Phase 2 / Phase 3 | 2026-07-08 | NCT07532603 |